Navigation Links
Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
Date:10/7/2009

CRANBURY, N.J., Oct. 7 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company, announced today that groundbreaking cancer research scientist Robert A. Weinberg, Ph.D., a founding member of the Whitehead Institute for Biomedical Research and a Professor of Biology at MIT, has joined the company's Scientific Advisory Board.

Widely recognized for his discoveries of the first human oncogene (the ras oncogene that causes normal cells to form tumors), and the isolation of the first known tumor suppressor gene -- the Rb gene, Dr. Weinberg has long been recognized as a pioneer in cancer research.

"We are delighted to welcome Dr. Weinberg to our Scientific Advisory Board," commented Dr. Robert Shorr, CEO, of Cornerstone Pharmaceuticals. "Dr. Weinberg's accomplishments in cancer research are monumental and we believe his experience, guidance and vision will be of tremendous benefit to the Company."

Cornerstone Pharmaceuticals is currently recruiting patients with solid tumors to advance multiple Phase I/II human clinical trials of CPI-613, its lead drug to emerge from the company's Altered Energy Metabolism Directed (AEMD) technology platform. CPI-613 is the first drug in a new chemical class that, through a novel mechanism, targets metabolic changes that may be common to many cancer types. CPI-613 is being evaluated in a Phase I/II single agent trial for patients who have failed all other therapy as well as in a Phase I/II combination trial with gemcitabine in newly diagnosed or relapsed patients determined to be treated with gemcitabine. Pancreatic cancer, like many solid tumors, typically has a poor prognosis, spreads rapidly and often goes undetected in its early stages. CPI-613 has been granted orphan drug status by the US FDA for pancreatic cancer.

"I am pleased to join Cornerstone Pharmaceuticals as a member of its Scientific Advisory Board and look forward to
'/>"/>

SOURCE Cornerstone Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced ... - Global Forecasts to 2019" report to their ... is estimated to grow expected to reach $9.37 billion ... to 2019. Factors such as ... constraints, increasing privatization in the healthcare sector, and rising ...
(Date:7/28/2015)... , July 21, 2015 ... announced the addition of the "Craniomaxillofacial Implants ... Trends and Forecast 2014 - 2022" report ... the craniomaxillofacial implants market studies the current and ... are rapidly gaining popularity in the global market ...
(Date:7/28/2015)... July 28, 2015 The Physician-Patient Alliance for ... fundraising campaign, " Surviving Your Hospital Stay ." ... they deserve! None of these patients went home from ... Executive Director, PPAHS) referring to the patient stories ... National Coalition to Promote Continuous Monitoring of Patients on ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... 14, 2011 Armanino Consulting today announced that ... AX implementation and the integration of Microsoft Dynamics ... to streamline the production of digital X-ray sensors ... is a comprehensive business management solution for midsize ...
... 14, 2011 Awarepoint Corporation , the ... solutions for health care, and MEDITECH , ... (HCIS), today announced a collaboration to integrate technologies ... location and critical milestone tracking within MEDITECH,s enterprise-wide ...
Cached Medicine Technology:Armanino Consulting Completes Integration of Microsoft Dynamics AX and Camstar MES for dpiX 2Armanino Consulting Completes Integration of Microsoft Dynamics AX and Camstar MES for dpiX 3Awarepoint Corporation and MEDITECH Collaborate to Integrate Technology Platforms 2Awarepoint Corporation and MEDITECH Collaborate to Integrate Technology Platforms 3
(Date:7/28/2015)... ... 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very best ... Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma ... proud to be bestowed such a prestigious title. , The Press Democrat was ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new ... for inmates who continued methadone maintenance treatment (MMT) during incarceration versus those subjected ... relapse to opiate use (1) and more likely to require hospitalization or emergency ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part ... and one of the first five hospitals in the nation, to implant the newly ... on July 23, and all are in good condition. , The CoreValve® Evolut® R ...
(Date:7/28/2015)... Francisco, California (PRWEB) , ... July 28, 2015 , ... ... the results from a recent survey (1) examining consumers’ perspectives on digital ... June 17-24, 2015, covered topics such as innovations in digital health, level of trust ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... Dr. ... diseases. , The talk took place from noon to 1 p.m. Tuesday, June 23, ... Panama City, Fla. , Dr. Ahmad is board-certified in colorectal surgery and has ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... doctors in Tamilnadu said that the doctors in Delhi ... duty. Hence it is asking the doctors to call ... of Institute of Thoracic Medicine, Tambaram, said that though ... proposed reservation in elite educational institutions, it said that ...
... vital that children are administered the correct dosage of ... a hospital.// A new study presented at the Society ... error rates in a program called "LA Kids." ... a Broselow tape (a weight-estimating tool) and report weight-based ...
... get themselves screened for HIV, city-run medical clinics have relaxed ... the new rule, counseling sessions and written informed consent is ... is a verbal consent from the patient. ,This ... relaxed with respect to consent and counseling. Two hospitals and ...
... discovered an embezzlement of nearly Rs.4.4 million from funds ... the fund use were discovered during checking of records ... education. ,The embezzlement was done by four ... 1997 and March 2005. ,Out of this, ...
... for the Indian School Certificate Examination (CISCE) declared the results ... Wednesday// with girls outshining boys for the second consecutive year. ... examination was 96.9 as against 95.29 among boys. Similarly, in ... compared to 91 percent among the boys. ...
... of premature infants from damage. An ongoing study, which ... an early finding in a trial being undertaken to ... of apnoea of prematurity. ,Apnoea of prematurity ... are underdeveloped and the central nervous system, which automatically ...
Cached Medicine News:Health News:Children Need Different Dosage In Cardiac Arrest 2Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2
Bruns bone curette, 9, oval, solid actagonal handle....
15" overall length, 5" handle....
15" overall length, 9" handle....
...
Medicine Products: